PTCT Sale Disclosure
Schmertzler Michael · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$199.34K
Schmertzler Michael Director
PTCT
PTC Therapeutics
PTCT
Transaction date
Sep 16, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 2 days later
PTCT daily price context
Close on/before transaction
$67.59
Sep 16, 2026
Close before public filing
$68
Sep 17, 2026
Return since public filing
-3.86%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,994 shares @ $66.58
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001288952-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.35M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Sale | Sep 17, 2026 | $652.8K |
| Ptc Therapeutics, Inc. PTCT | Sale | Sep 17, 2026 | $25.74K |
| Ptc Therapeutics, Inc. PTCT | Sale | Sep 16, 2026 | $471.85K |
| Ptc Therapeutics, Inc. PTCT Current | Sale | Sep 16, 2026 | $199.34K |